![[Jcount.com]](https://www.jcount.com/wp-content/uploads/2014/08/jcount150X50.png)
![[Jcount.com]](https://www.jcount.com/wp-content/uploads/2014/08/jcountstartupslogo1.png)
What does Intact Vascular do?
Intact Vascular, is a medical device company which develops minimally invasive peripheral vascular products. Its product, The Tack-It Endovascular System is designed for optimizing peripheral balloon angioplasty which results in treating peripheral artery disease. The technology offers physicians a new treatment option for treating peripheral artery disease. This company is dedicated to developing safe and efficient products for patients and for physicians who use these products.
Its medical devices are for minimally invasive procedures for peripheral artery diseases.
How much Intact Vascular was funded?
Intact Vascular raised $38.9 M in Series B round on May 14th, 2015 from H.I.G. BioVentures, New Enterprise Associates and Quaker Partners.
Previous funding
$1.3M in Debt Financing round on February 22, 2012
$15.5M in Series A round on September 5, 2012 from Quaker BioVentures and H.I.G. BioVentures
$4.7M in Debt Financing round on December 20, 2013
$3M in Debt Financing round on March 20, 2015
What is next for Intact Vascular?
Intact Vascular will use the $38.9 M raised in Series B funding venture capital financing to accelerate the development and FDA approval of its patent Tack Endovascular System. The company will use the fund to move rapidly into the pivotal clinical trial work in peripheral artery diseases and for exploring new applications of this novel approach in vascular repair.
More about Intact Vascular
Intact Vascular, is a privately held medical device company. It was founded on January 1st, 2011 by Robert M. Giasolli. It has its headquarters in Wayne, PA. Its product, The Tack Endovascular System is designed in such a way that it optimizes the results of percutaneous balloon angioplasty for treating peripheral artery diseases. This technology is offering physicians a new treatment option for treating the disease.
The company is dedicated to developing safe, easy and efficacious product for vascular disease suffering patients and for the physicians who are treating these patients.
